TLPH Q3 2019 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena

TLPHTalphera, Inc.

$18M

Q3 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$608,000+61.3% YoY

Gross Profit

-$3M-427.3% margin

Operating Income

-$14M-2226.0% margin

Net Income

-$13M-2093.9% margin

EPS (Diluted)

$-3.20

QoQ Revenue Growth

-35.4%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$13M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$105M

Total Liabilities

$133M

Stockholders' Equity

-$28M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$608,000	$377,000	+61.3%
Gross Profit	-$3M	-$4M	+37.2%
Operating Income	-$14M	-$9M	-45.1%
Net Income	-$13M	-$12M	-2.2%